Mitrix bio

Mitrix Bio is a biotechnology company pioneering a novel approach to regenerative medicine through bioreactor-grown mitochondrial transplantation. The company's core technology involves producing young, healthy mitochondria at scale, encapsulating them in targeted vesicles called 'Mitlets,' and transplanting them to address age-related diseases driven by mitochondrial dysfunction. Their mission is to prototype the components and techniques for a fundamental advancement in human medicine targeting aging and cellular rejuvenation.